Prevalence of autoimmune diabetes among Aboriginal Australians: the Fremantle Diabetes Study Phase II

Timothy M. E. Davis; Christine S. Bundell; Stephen A. Paul Chubb; Daniel Mcaullay; Wendy A. Davis

doi:10.1111/imj.70029

Prevalence of autoimmune diabetes among Aboriginal Australians: the Fremantle Diabetes Study Phase II

Timothy M. E. Davis, Christine S. Bundell, Stephen A. Paul Chubb, Daniel Mcaullay, Wendy A. Davis

Internal Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

The prevalence of autoimmune diabetes was assessed in 113 indigenous and 1555 non-indigenous participants in the Fremantle Diabetes Study Phase II. Both type 1 diabetes (3.5% vs. 8.2%) and latent autoimmune diabetes of adults diagnosed based on glutamic acid decarboxylase antibody (GADA) positivity (1.0% vs. 5.7%) were lower in Aboriginal participants (P = 0.101 and 0.039 respectively). Six Aboriginals with GADA-negative type 2 diabetes were positive for tyrosine phosphatase-related islet antigen 2 antibodies but did not exhibit relative insulin deficiency.

Original language	English
Pages (from-to)	659-663
Number of pages	5
Journal	Internal Medicine Journal
Volume	55
Issue number	4
Early online date	18 Mar 2025
DOIs	https://doi.org/10.1111/imj.70029
Publication status	Published - Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/imj.70029Licence: CC BY

Cite this

@article{3f741fc41d48441ca1ee67351c50123b,

title = "Prevalence of autoimmune diabetes among Aboriginal Australians: the Fremantle Diabetes Study Phase II",

abstract = "The prevalence of autoimmune diabetes was assessed in 113 indigenous and 1555 non-indigenous participants in the Fremantle Diabetes Study Phase II. Both type 1 diabetes (3.5% vs. 8.2%) and latent autoimmune diabetes of adults diagnosed based on glutamic acid decarboxylase antibody (GADA) positivity (1.0% vs. 5.7%) were lower in Aboriginal participants (P = 0.101 and 0.039 respectively). Six Aboriginals with GADA-negative type 2 diabetes were positive for tyrosine phosphatase-related islet antigen 2 antibodies but did not exhibit relative insulin deficiency.",

keywords = "Autoimmune diabetes, Indigenous, Latent autoimmune diabetes of adults, Prevalence, Type 1 diabetes",

author = "Davis, {Timothy M. E.} and Bundell, {Christine S.} and Chubb, {Stephen A. Paul} and Daniel Mcaullay and Davis, {Wendy A.}",

year = "2025",

month = apr,

doi = "10.1111/imj.70029",

language = "English",

volume = "55",

pages = "659--663",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "John Wiley & Sons",

number = "4",

}

TY - JOUR

T1 - Prevalence of autoimmune diabetes among Aboriginal Australians

T2 - the Fremantle Diabetes Study Phase II

AU - Davis, Timothy M. E.

AU - Bundell, Christine S.

AU - Chubb, Stephen A. Paul

AU - Mcaullay, Daniel

AU - Davis, Wendy A.

PY - 2025/4

Y1 - 2025/4

N2 - The prevalence of autoimmune diabetes was assessed in 113 indigenous and 1555 non-indigenous participants in the Fremantle Diabetes Study Phase II. Both type 1 diabetes (3.5% vs. 8.2%) and latent autoimmune diabetes of adults diagnosed based on glutamic acid decarboxylase antibody (GADA) positivity (1.0% vs. 5.7%) were lower in Aboriginal participants (P = 0.101 and 0.039 respectively). Six Aboriginals with GADA-negative type 2 diabetes were positive for tyrosine phosphatase-related islet antigen 2 antibodies but did not exhibit relative insulin deficiency.

AB - The prevalence of autoimmune diabetes was assessed in 113 indigenous and 1555 non-indigenous participants in the Fremantle Diabetes Study Phase II. Both type 1 diabetes (3.5% vs. 8.2%) and latent autoimmune diabetes of adults diagnosed based on glutamic acid decarboxylase antibody (GADA) positivity (1.0% vs. 5.7%) were lower in Aboriginal participants (P = 0.101 and 0.039 respectively). Six Aboriginals with GADA-negative type 2 diabetes were positive for tyrosine phosphatase-related islet antigen 2 antibodies but did not exhibit relative insulin deficiency.

KW - Autoimmune diabetes

KW - Indigenous

KW - Latent autoimmune diabetes of adults

KW - Prevalence

KW - Type 1 diabetes

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:001446744900001&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1111/imj.70029

DO - 10.1111/imj.70029

M3 - Article

C2 - 40099758

SN - 1444-0903

VL - 55

SP - 659

EP - 663

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 4

ER -

Prevalence of autoimmune diabetes among Aboriginal Australians: the Fremantle Diabetes Study Phase II

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

MRFF - Community-based studies of diabetes and infectious diseases

Cite this

Prevalence of autoimmune diabetes among Aboriginal Australians: the Fremantle Diabetes Study Phase II

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Projects

MRFF - Community-based studies of diabetes and infectious diseases

Cite this